The American Journal of Managed Care4 天
The High Cost of Shortages of Low-Cost Chemotherapy
The 2023 chemotherapy shortage led to a 60% drop in cisplatin use for head and neck cancer, with costly substitutes ...
Germ Cell Tumors Market to Register Significant Growth at a CAGR of 5.5% by 2034 | DelveInsight
DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, ...
Gene inhibition provides potential way to overcome cancer cells' resistance to chemotherapy ...
A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...